Apyx Medical Corporation (APYX)
NASDAQ: APYX · IEX Real-Time Price · USD
1.600
0.00 (0.00%)
May 20, 2024, 1:53 PM EDT - Market open
Apyx Medical Revenue
Apyx Medical had revenue of $50.45M in the twelve months ending March 31, 2024, with 14.25% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.24M, a -15.63% decrease year-over-year. In the year 2023, Apyx Medical had annual revenue of $52.35M with 17.61% growth.
Revenue (ttm)
$50.45M
Revenue Growth
+14.25%
P/S Ratio
1.10
Revenue / Employee
$200,202
Employees
252
Market Cap
55.16M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 52.35M | 7.84M | 17.61% |
Dec 31, 2022 | 44.51M | -4.01M | -8.26% |
Dec 31, 2021 | 48.52M | 20.81M | 75.08% |
Dec 31, 2020 | 27.71M | -524.00K | -1.86% |
Dec 31, 2019 | 28.24M | 11.63M | 70.04% |
Dec 31, 2018 | 16.61M | 6.37M | 62.25% |
Dec 31, 2017 | 10.23M | 1.42M | 16.04% |
Dec 31, 2016 | 8.82M | -20.70M | -70.13% |
Dec 31, 2015 | 29.52M | 1.84M | 6.64% |
Dec 31, 2014 | 27.68M | 4.02M | 16.99% |
Dec 31, 2013 | 23.66M | -4.01M | -14.50% |
Dec 31, 2012 | 27.67M | 2.26M | 8.89% |
Dec 31, 2011 | 25.41M | 1.18M | 4.87% |
Dec 31, 2010 | 24.23M | -2.72M | -10.10% |
Dec 31, 2009 | 26.95M | -1.14M | -4.07% |
Dec 31, 2008 | 28.10M | -682.16K | -2.37% |
Dec 31, 2007 | 28.78M | 2.10M | 7.88% |
Dec 31, 2006 | 26.68M | 6.47M | 31.99% |
Dec 31, 2005 | 20.21M | -283.96K | -1.39% |
Dec 31, 2004 | 20.50M | 4.38M | 27.16% |
Dec 31, 2003 | 16.12M | 3.67M | 29.50% |
Dec 31, 2002 | 12.45M | 913.76K | 7.92% |
Dec 31, 2001 | 11.53M | 1.60M | 16.07% |
Dec 31, 2000 | 9.94M | 243.17K | 2.51% |
Dec 31, 1999 | 9.69M | 1.25M | 14.82% |
Dec 31, 1998 | 8.44M | 1.07M | 14.52% |
Dec 31, 1997 | 7.37M | -114.62K | -1.53% |
Dec 31, 1996 | 7.49M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Equillium | 37.89M |
DarioHealth | 19.04M |
Carisma Therapeutics | 15.07M |
Enzo Biochem | 12.81M |
Milestone Scientific | 9.48M |
InspireMD | 6.48M |
EUDA Health Holdings | 3.71M |
APYX News
- 11 days ago - Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook - Business Wire
- 11 days ago - Apyx Medical Corporation Announces Board Leadership Transition - Business Wire
- 25 days ago - Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024 - Business Wire
- 5 weeks ago - Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit - Business Wire
- 2 months ago - Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook - Business Wire
- 2 months ago - Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024 - Business Wire
- 3 months ago - Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting - Business Wire
- 4 months ago - Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body - Business Wire